Pharvaris B.V.

NASDAQ
PHVS
Stock
Yield per half year: -33.83%
Dividend yield: 0%
Sector: Healthcare

Share chart Pharvaris B.V.

Extended chart Simple chart
Financial Markets by TradingView

About Pharvaris B.V.

Pharvaris B. V., клиническая биофармацевтическая компания, занимается открытием и разработкой методов лечения редких заболеваний. Компания разрабатывает PHA121, низкомолекулярный антагонист брадикинина В2-рецептора для лечения наследственного ангионевротического отека. Она работает в Нидерландах, Швейцарии и Соединенных Штатах. Компания была зарегистрирована в 2015 году и базируется в Лейдене, Нидерланды.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2021-02-05
ISIN NL00150005Y4
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета eur
Див.доход ао 0
Сайт link
Цена ао 15.99
Change price per day: 0% (15.99)
Change price per week: -4.19% (16.69)
Change price per month: +1.01% (15.83)
Change price per 3 month: +1.2% (15.8)
Change price per half year: -33.83% (24.165)
Change price per year: -17.58% (19.4)
Change price per 3 year: -20.8% (20.19)
Change price per year to date: -15.08% (18.83)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 2.37 6
P/E 0 0
EV/EBITDA -5.5 0
Total: 3
Efficiency
Title Value Grade
ROA, % -24.76 0
ROE, % -25.71 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.0025 10
Total: 8.4
Growth impulse
Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1111.76 10
Yield EPS, % 849.59 10
Total: 8
More

Main owners

Institutions Volume Share, %
General Atlantic, L.P. 6 156 252 11.81
FMR, LLC 5 192 984 9.97
venBio Partners LLC 4 919 504 9.44
Foresite Capital Management IV, LLC 4 038 842 7.75
Bain Capital Life Sciences Investors, LLC 3 904 319 7.49
Viking Global Investors, L.P. 3 656 923 7.02
VR Adviser, LLC 3 395 606 6.52
Cormorant Asset Management, LP 1 711 460 3.28
Novo Holdings A/S 1 539 325 2.95
EcoR1 Capital, LLC 900 000 1.73

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Ms. Anna Nijdam M.Sc., R.A. Head of Strategic Finance & Principal Accounting Officer N/A 1981 (44 years)
Dr. Peng Lu M.D., Ph.D. Chief Medical Officer N/A 1978 (47 years)
Dr. Morgan Conn Ph.D. Chief Business Officer N/A 1969 (56 years)
Maryann Cimino Director of Corporate Relations N/A
Mr. Wim Souverijns Ph.D. Chief Commercial Officer N/A 1971 (54 years)
Dr. Anne A. Lesage Ph.D. Chief Early Development Officer N/A 1961 (64 years)
Mr. Berndt Axel Edvard Modig CPA, M.B.A. Co-Founder, CEO & Executive Director 541.59k 1959 (66 years)
Dr. Stefan Abele Ph.D. Chief Technology Operations Officer N/A 1970 (55 years)
Ms. Annick Deschoolmeester Chief Human Resources Officer N/A 1973 (52 years)
Mr. David W. Nassif J.D. CFO & Corporate Secretary 1954 (71 year)

About company

Address: Netherlands, Leiden, Emmy Noetherweg 2 - Open in google maps, Open in yandex maps
Website: https://pharvaris.com